Intrinsic Value of S&P & Nasdaq Contact Us

NeuroPace, Inc. NPCE NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$19.00
+23.8%

Stock Statistics — NPCE

NeuroPace, Inc. (NPCE) has a market capitalization of $516.79M and trades at $15.35. The 52-week range is 7.563-18.975.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -23.3, Earnings Per Share (EPS) of $-0.66, annual revenue of $99.99M.

The stock has a beta of 1.88, operates in the Healthcare sector.

Trading Data
Current Price$15.35
52-Week Range7.563-18.975
Volume126.25K
Avg Volume (30D)190.53K
Market Cap$516.79M
Beta (1Y)1.88
Company
IPO Date2021-04-22
Employees184
CEOJoel D. Becker
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS6412881053
CUSIP641288105
Income (Latest Year)
Revenue$99.99M
Gross Profit$77.22M
EBITDA$-14.39M
Operating Income$-16.34M
Net Income$-21.47M
EPS$-0.66
EPS Diluted$-0.66
Shares Outstanding$32.72M
Balance Sheet (Latest Year)
Total Assets$105.57M
Current Assets$94.07M
Cash & ST Investments$61.06M
Total Liabilities$86.53M
Total Debt$70.84M
Net Debt$49.15M
Total Equity$19.03M
Debt / Equity3.72
Valuation Ratios
P/E Ratio-23.3
P/S Ratio5.17
P/B Ratio27.16
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message